Germline mutations of the VHL gene predispose affected individuals to the development of benign and malignant tumors in several systems including the central nervous system (CNS), and visceral organs such as the kidneys, pancreas, adrenals, and reproductive organs. This evidence concerns the gene VHL and cancer.